Or Refractory Indolent B-cell Non-hodgkin Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-12-19
Clinical Trial Update: Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma [Phase 1]
The document reports the completion of a Phase 1 trial of ME-401 in patients with relapsed or refractory indolent B-cell non-Hodgkin's lymph…